CeriBell, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CBLL Nasdaq 3840 www.ceribell.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CeriBell, Inc.

CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium - Mar 7th, 2026 9:15 am
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot - Mar 7th, 2026 8:23 am
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord - Mar 2nd, 2026 8:23 am
CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ... - Feb 24th, 2026 10:03 pm
CeriBell Q4 Earnings Call Highlights - Feb 24th, 2026 8:06 pm
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates - Feb 24th, 2026 7:55 pm
CeriBell, Inc. Q4 2025 Earnings Call Summary - Feb 24th, 2026 6:03 pm
CeriBell (CBLL) Q4 2025 Earnings Call Transcript - Feb 24th, 2026 4:06 pm
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results - Feb 24th, 2026 2:05 pm
Ceribell to Participate in Upcoming March Investor Conferences - Feb 18th, 2026 2:05 pm
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - Feb 10th, 2026 2:05 pm
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion - Jan 14th, 2026 7:21 am
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection - Jan 6th, 2026 10:34 am
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution - Jan 5th, 2026 6:00 am
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Dec 30th, 2025 2:05 pm
CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution - Dec 12th, 2025 8:02 am
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution - Dec 9th, 2025 6:00 am
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates - Nov 24th, 2025 6:00 am
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference - Nov 19th, 2025 2:05 pm
CeriBell (CBLL) Q3 2025 Earnings Call Transcript - Nov 8th, 2025 10:06 pm